FDA panel OKs Bard's Lutonix balloon

An FDA advisory panel recommends approval for C.R. Bard's Lutonix drug-eluting balloon for treating peripheral artery disease.

An FDA advisory panel today recommended approval for the Lutonix drug-eluting balloon made by C.R. Bard (NYSE:BCR).

C.R. Bard, Food & Drug Administration (FDA)

News Well, Peripheral Artery Disease, Pre-Market Approval (PMA), Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1v6vEdM